IDNNA
From Self-sufficiency
Revision as of 15:16, 17 August 2010 by Nirmos (Talk) (Corrected systematic name. Removed one redundant category.)
IDNNA | |
---|---|
File:IDNNA.png | |
[2-(4-Iodo-2,5-dimethoxyphenyl)-1-methylethyl]dimethylamine | |
Other names 2,5-Dimethoxy-4-iodo-N,N-dimethylamphetamine 2,5-Dimethoxy-4-iodo-1-ethyl-(alpha-methyl)amine | |
style="background: #F8EABA; text-align: center;" colspan="2" | Identifiers | |
CAS number | 67707-78-2 |
SMILES | Script error: No such module "collapsible list". |
style="background: #F8EABA; text-align: center;" colspan="2" | Properties | |
Molecular formula | C13H20NO2I |
Molar mass | 349.211 g/mol |
Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) | |
Infobox references |
IDNNA, or 2,5-dimethoxy-4-iodo-N,N-dimethylamphetamine, is a lesser-known psychedelic drug and a substituted amphetamine. It is also the N,N-dimethyl analog of DOI. IDNNA was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 2.6 mg, and the duration unknown. IDNNA produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of IDNNA.
See also
External links
This psychoactive drug-related article is a stub. You can help ssf by expanding it. |